147 related articles for article (PubMed ID: 16166789)
1. Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance.
Koike K
Intervirology; 2006; 49(1-2):51-7. PubMed ID: 16166789
[TBL] [Abstract][Full Text] [Related]
2. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
Koike K; Moriya K
J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein.
Miyamoto H; Moriishi K; Moriya K; Murata S; Tanaka K; Suzuki T; Miyamura T; Koike K; Matsuura Y
J Virol; 2007 Feb; 81(4):1727-35. PubMed ID: 17135326
[TBL] [Abstract][Full Text] [Related]
4. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolism and liver disease in hepatitis C viral infection.
Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression.
Alberstein M; Zornitzki T; Zick Y; Knobler H
J Viral Hepat; 2012 Jan; 19(1):65-71. PubMed ID: 22187946
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.
Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Tsukamoto K; Kimura S; Moriya K; Koike K
Gastroenterology; 2004 Mar; 126(3):840-8. PubMed ID: 14988838
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
Kawaguchi T; Yoshida T; Harada M; Hisamoto T; Nagao Y; Ide T; Taniguchi E; Kumemura H; Hanada S; Maeyama M; Baba S; Koga H; Kumashiro R; Ueno T; Ogata H; Yoshimura A; Sata M
Am J Pathol; 2004 Nov; 165(5):1499-508. PubMed ID: 15509521
[TBL] [Abstract][Full Text] [Related]
9. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
Bernsmeier C; Duong FH; Christen V; Pugnale P; Negro F; Terracciano L; Heim MH
J Hepatol; 2008 Sep; 49(3):429-40. PubMed ID: 18486982
[TBL] [Abstract][Full Text] [Related]
10. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.
Kawaguchi T; Ide T; Taniguchi E; Hirano E; Itou M; Sumie S; Nagao Y; Yanagimoto C; Hanada S; Koga H; Sata M
Am J Gastroenterol; 2007 Mar; 102(3):570-6. PubMed ID: 17222321
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice.
Lerat H; Imache MR; Polyte J; Gaudin A; Mercey M; Donati F; Baudesson C; Higgs MR; Picard A; Magnan C; Foufelle F; Pawlotsky JM
J Biol Chem; 2017 Aug; 292(31):12860-12873. PubMed ID: 28559285
[TBL] [Abstract][Full Text] [Related]
12. Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis.
Pascarella S; Clément S; Guilloux K; Conzelmann S; Penin F; Negro F
J Med Virol; 2011 Jun; 83(6):1005-15. PubMed ID: 21503913
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance.
Banerjee S; Saito K; Ait-Goughoulte M; Meyer K; Ray RB; Ray R
J Virol; 2008 Mar; 82(6):2606-12. PubMed ID: 18160431
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver.
Mori Y; Moriishi K; Matsuura Y
Int J Biochem Cell Biol; 2008; 40(8):1437-42. PubMed ID: 18321762
[TBL] [Abstract][Full Text] [Related]
15. Animal models in the study of hepatitis C virus-associated liver pathologies.
Lerat H; Higgs M; Pawlotsky JM
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):341-52. PubMed ID: 21651352
[TBL] [Abstract][Full Text] [Related]
16. Current understanding of insulin resistance in hepatitis C.
Kaddai V; Negro F
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):503-16. PubMed ID: 21780897
[TBL] [Abstract][Full Text] [Related]
17. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
Negro F
J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
[TBL] [Abstract][Full Text] [Related]
18. Dual behavior of HCV Core gene in regulation of apoptosis is important in progression of HCC.
Jahan S; Ashfaq UA; Khaliq S; Samreen B; Afzal N
Infect Genet Evol; 2012 Mar; 12(2):236-9. PubMed ID: 22266242
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1527-31. PubMed ID: 9225025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
